CClinicalTrials.gg
Status unknownNCT03264378Updated Apr 30, 2021

Partnership in Implementation Science for Geriatric Mental Health (PRISM)

An interventional study of Physical Exercise Intervention in Behavioral and Psychological Symptoms of Dementia (BPSD), sponsored by Brigham and Women's Hospital. Status unknown at 1 site in Thailand. Open to participants aged 55 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-30.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Study summary

The Partnership in Implementation Science for Geriatric Mental Health (PRISM) project proposes an evidence-based physical exercise intervention for older adults who exhibit behavioral and psychological symptoms of dementia (BPSD). The proposed evaluation study will conduct a randomized controlled trial with a Hybrid Type 3 design to compare the intervention arm that implements the culturally-adapted GTO model (GTO-ThAI) to deliver implementation support, with a control arm, which receives usual top-down administrative instruction for implementing a policy initiative.

Read the detailed description

The overall goal of this project is to establish a hub to integrate implementation research for scaling up sustainable, evidence-based mental health interventions with research capacity-building activities for East Asia. Specific scale-up study aims include: Aim 1: Assessing readiness for implementing the evidence-based physical exercise intervention for improving mental health of older adults in participating provinces of Thailand; Aim 2: Developing the GTO-ThAI implementation support model through a pre-implementation case study and formative evaluation; and Aim 3: Evaluation of implementation strategies and clinical outcomes through a hybrid Type 3 randomized trial to test an evidence-based implementation support strategy (i.e., the GTO-ThAI model) that emphasizes a systematic process to address implementation barriers to the delivery of the evidence-based physical exercise intervention (PEI), compared with the existing standard administrative procedures for delivering the same PEI.

02

Conditions studied

  • Behavioral and Psychological Symptoms of Dementia (BPSD)

Browse trials for

03

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • (a) adults who are aged 55 and older,
  • (b) screen positive for dementia,
  • (c) screen positive for BPSD, and
  • (d) having a caregiver who is willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • (a) caregivers who are cognitively not intact, and/or
  • (b) not willing to participate in the intervention.
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    PEI-GTO-ThAI

    Physical exercise intervention (PEI) supported by the GTO-ThAI Implementation Model

    Behavioral: Physical Exercise Intervention

  • Active comparator
    PEI-Standard

    Physical exercise intervention (PEI) supported by the standard governmental administrative procedures

    Behavioral: Physical Exercise Intervention

Interventions

  • BehavioralPhysical Exercise Intervention

    The 12-week physical exercise intervention will be delivered by trained community health workers (CHW) who are supervised by nurses. The CHW will visit the patient's home-3 sessions per week for the first 2 weeks, followed by weekly visits for 6 weeks, and then weekly telephone support for 4 weeks-to instruct the family caregiver and the patient in the exercise routine. Each session includes physical activities designed to promote gentle stretching, strength, balance, flexibility, and endurance, with a progressive schedule (i.e., the total length of time increases from 10 minutes up to 30 minutes maximum) and its intensity adjusted based on the participant's level of fitness.

05

What researchers measure

Primary outcomes

  1. Implementation outcome score

    Adapted from the Quality Implementation Tool (Meyer et al., 2012), using a total score based on average of ratings, by site implementation team leaders, on a 7-point Likert scale over 48 items across eight dimensions of implementation (e.g. adoption, fidelity, dosage, program reach, differentiation, quality of implementation, implementation cost, sustainability).

    Time frame: Up to 12 months

Secondary outcomes

  1. Behavioral and psychological symptoms of dementia (BPSD)

    BPSD will be assessed by the Neuropsychiatric Inventory (NPI), using the total score obtained by summing all the individual domain total scores; each domain score is the product of the frequency score multiplied by the severity score for that behavioral domain.

    Time frame: Up to 12 months

06

Study locations

1 of 1 sites recruiting
  • Ministry of Public Health
    Bangkok, Thailand
    Recruiting
07

References and documents

Publications

  • Chen H, Levkoff S, Chuengsatiansup K, Sihapark S, Hinton L, Gallagher-Thompson D, Tongsiri S, Wisetpholchai B, Fritz S, Lamont A, Domlyn A, Wandersman A, Marques AH. Implementation Science in Thailand: Design and Methods of a Geriatric Mental Health Cluster-Randomized Trial. Psychiatr Serv. 2022 Jan 1;73(1):83-91. doi: 10.1176/appi.ps.202000028. Epub 2021 Jun 15. PubMed 34126778 ↗

Individual participant data

Plan to share: No — We don't have a plan to share individual participant data.

08

Registry details

Key details

Study ID
NCT03264378
Lead sponsor
Brigham and Women's Hospital
Collaborators
Society and Health Institute (Thailand), Shanghai Mental Health Center (China), University of South Carolina, University of California, Davis
Responsible party
Hongtu Chen (Assistant Professor, Brigham and Women's Hospital) — Principal investigator
First posted
Aug 29, 2017
Start date
Jun 1, 2020
Primary completion
Jun 30, 2021 (estimated)
Completion
Sep 30, 2021 (estimated)
Last update
Apr 30, 2021

Study contacts

Komatra Chuengsatiansup, MD
Contact
loxlix@gmail.com
+66814411401
Hongtu Chen, PhD
principal investigator · Brigham and Women's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion